open access

Vol 5, No 2 (2002)
Published online: 2002-06-07
Submitted: 2012-01-23
Get Citation

Comparison of99mTc-alafosfalin and 67Ga-citrate in a mouse model of bacterial infection

Chris Tsopelas, Stan Penglis, F. Dylan L. Bartholomeusz
Nucl. Med. Rev 2002;5(2):93-97.

open access

Vol 5, No 2 (2002)
Published online: 2002-06-07
Submitted: 2012-01-23

Abstract

BACKGROUND: The antibiotic-peptide 99mTc-alafosfalin was assessed as an infection imaging agent in Staphylococcus aureas infected mice by comparison with 99mGa-citrate, and also examined for influence of septic status on tracer biodistribution by comparison with normal mice.
MATERIAL AND METHODS: Intramuscular doses of S. aureus were administered into the right thigh muscle of mice and the infection was allowed to develop for 20 hours. In separate experiments, 99mTc-alafosfalin and 67Ga-citrate were subsequently administered and allowed to localise. Quantitative organ distribution studies were performed in conjunction with scintigraphic images at 1 and 4 hours post injection. An additional biodistribution with 99mTc-alafosfalin in normal mice was also performed.
RESULTS: 99mTc-alafosfalin was predominantly renal excreted, with low liver, intestine and bone uptake. There was no difference in the uptake of these organs when infected mice were compared with normal mice. 99mTc-alafosfalin activity in the intestine at 1 and 4 hours was substantially less than 67Ga-citrate. For 99mTc-alafosfalin, infected/non-infected thigh ratios of 2.8/1.0 and 3.6/1.0 were determined at 1 and 4 hours post injection respectively. 67Ga-citrate gave ratios of 1.6/1.0 and 3.7/1.0 at the corresponding time points.
CONCLUSIONS: 99mTc-alafosfalin uptake was more rapid than 67Ga-citrate, yet diffuse at the infectious sites in mice. The small and juvenile mouse model resulted in uptake of the phosphonic acid tracer by active bone growth areas which may be a disadvantage. This 99mTc-antibiotic peptide has potential as an infection imaging agent, and will be investigated further in another rodent infection model in the future.

Abstract

BACKGROUND: The antibiotic-peptide 99mTc-alafosfalin was assessed as an infection imaging agent in Staphylococcus aureas infected mice by comparison with 99mGa-citrate, and also examined for influence of septic status on tracer biodistribution by comparison with normal mice.
MATERIAL AND METHODS: Intramuscular doses of S. aureus were administered into the right thigh muscle of mice and the infection was allowed to develop for 20 hours. In separate experiments, 99mTc-alafosfalin and 67Ga-citrate were subsequently administered and allowed to localise. Quantitative organ distribution studies were performed in conjunction with scintigraphic images at 1 and 4 hours post injection. An additional biodistribution with 99mTc-alafosfalin in normal mice was also performed.
RESULTS: 99mTc-alafosfalin was predominantly renal excreted, with low liver, intestine and bone uptake. There was no difference in the uptake of these organs when infected mice were compared with normal mice. 99mTc-alafosfalin activity in the intestine at 1 and 4 hours was substantially less than 67Ga-citrate. For 99mTc-alafosfalin, infected/non-infected thigh ratios of 2.8/1.0 and 3.6/1.0 were determined at 1 and 4 hours post injection respectively. 67Ga-citrate gave ratios of 1.6/1.0 and 3.7/1.0 at the corresponding time points.
CONCLUSIONS: 99mTc-alafosfalin uptake was more rapid than 67Ga-citrate, yet diffuse at the infectious sites in mice. The small and juvenile mouse model resulted in uptake of the phosphonic acid tracer by active bone growth areas which may be a disadvantage. This 99mTc-antibiotic peptide has potential as an infection imaging agent, and will be investigated further in another rodent infection model in the future.
Get Citation

Keywords

technetium-99m-alafosfalin; antibiotic-peptide; infection imaging

About this article
Title

Comparison of99mTc-alafosfalin and 67Ga-citrate in a mouse model of bacterial infection

Journal

Nuclear Medicine Review

Issue

Vol 5, No 2 (2002)

Pages

93-97

Published online

2002-06-07

Bibliographic record

Nucl. Med. Rev 2002;5(2):93-97.

Keywords

technetium-99m-alafosfalin
antibiotic-peptide
infection imaging

Authors

Chris Tsopelas
Stan Penglis
F. Dylan L. Bartholomeusz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl